327 related articles for article (PubMed ID: 23833274)
1. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
Asrih M; Jornayvaz FR
J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
[TBL] [Abstract][Full Text] [Related]
2. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
3. The role of cytokines in non-alcoholic fatty liver disease.
Tilg H
Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908
[TBL] [Abstract][Full Text] [Related]
4. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
Byrne CD; Targher G
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
[TBL] [Abstract][Full Text] [Related]
5. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
6. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.
Gariani K; Philippe J; Jornayvaz FR
Diabetes Metab; 2013 Feb; 39(1):16-26. PubMed ID: 23266468
[TBL] [Abstract][Full Text] [Related]
8. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
9. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Yki-Järvinen H
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
[TBL] [Abstract][Full Text] [Related]
10. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.
Diehl AM
Clin Liver Dis; 2004 Aug; 8(3):619-38, x. PubMed ID: 15331067
[TBL] [Abstract][Full Text] [Related]
12. Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease.
Yang J; Guan Y
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():105-11. PubMed ID: 23855304
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Pan MH; Lai CS; Tsai ML; Ho CT
Mol Nutr Food Res; 2014 Jan; 58(1):147-71. PubMed ID: 24302567
[TBL] [Abstract][Full Text] [Related]
14. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study).
Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer C
Metabolism; 2011 Jul; 60(7):969-75. PubMed ID: 21040936
[TBL] [Abstract][Full Text] [Related]
15. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
Orlik B; Handzlik G; Olszanecka-Glinianowicz M
Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
Tilg H; Moschen AR
Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome and nonalcoholic fatty liver disease.
Collantes RS; Ong JP; Younossi ZM
Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
19. Review: The role of insulin resistance in nonalcoholic fatty liver disease.
Utzschneider KM; Kahn SE
J Clin Endocrinol Metab; 2006 Dec; 91(12):4753-61. PubMed ID: 16968800
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
